Ultomiris HI IV infusion 1100mg/11mL, from Alexion Pharma, features Ravulizumab (genetical recombination). This injectable drug (YJ code: 6399427A3020) is provided as 1,100mg in 11mL per bottle. It is indicated for the treatment of specific complement-mediated diseases like PNH and aHUS.
Ultomiris HI IV infusion 1100mg/11mL
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).